fbpx

Johnson

Scrapping COVID Patents: PM Johnson needs to resist populist calls

FOR IMMEDIATE RELEASE:

Image

CONTACT:

Fred Roeder, Managing Director, Consumer Choice Center

Scrapping COVID Patents: PM Johnson needs to resist populist calls

London, UK –  In a report published today by the House of Commons International Trade Committee, Members of Parliament suggest to allow for compulsory licensing of drugs for COVID-19. Under compulsory licensing laws, a government has the power to revoke patent rights from innovators or companies if a discovery they made provides vital treatment or protection related to a national health emergency. Fred Roeder, Health Economist and Managing Director of the Consumer Choice Center warns that such erosion of intellectual property would lead to the opposite and eventually harm patients:

“Compulsory licensing is threatening to move the goalposts on how intellectual property rights are protected. If domestic and foreign companies are prevented from retaining their patent licenses, this could hinder the production and supply of essential goods to the population further than they already are. A compulsory licensing bill could place even more barriers for pharmaceutical innovators, which could further discourage these kinds of companies from investing or listing their drugs in the UK.

There are many ways to make easier access to vaccines and drugs for example a mutual recognition of FDA and EMA approvals and fast-tracking some type of medicines. In order to be prepared for the next pandemic, we need to increase and not curb incentives for innovation. Right now we need to do everything that makes pharmaceutical research more agile – Introducing compulsory licensing on COVID drugs and vaccines is not the right way. While might help in the short term but jeopardizes our ability to tackle health crises early on in the long run,” concludes Roeder.

***CCC’ Fred Roeder is available to speak with accredited media on consumer regulations and healthcare issues. Please send media inquiries HERE.***

 

The CCC represents consumers in over 100 countries across the globe. We closely monitor regulatory trends in Ottawa, Washington, Brussels, Geneva and other hotspots of regulation and inform and activate consumers to fight for #ConsumerChoice. Learn more at consumerchoicecenter.org

After another big lawsuit bites the dust, can we admit it’s time for legal reform?

It seems California isn’t so lawsuit crazy after all. Last Monday, Los Angeles jurors announced their ruling in just one of the dozens of lawsuits currently making their way through the courts on baby powder made by Johnson & Johnson. The jury found the company was not at fault for a woman’s mesothelioma diagnosis.

The trial brought forth experts from all stripes who presented their evidence and conclusions on whether the talc used in the baby powder produced by the Philadelphia-based company contained asbestos.

This is one instance in which a jury has sided with the scientific evidence, but that’s not often the case.

We shouldn’t forget that it was a California jury that initially awarded $2 billion to plaintiffs in a case considering whether the glyphosate found in Round-Up made by Monsanto, now a subsidiary of Bayer, caused cancer.

The judge, though, eventually reduced the verdict to $78 million to avoid the “arbitrary award” first conjured up by the tort lawyers. And that’s considering no major national body has deemed glyphosate to be carcinogenic.

In 2016, after the first $72 million verdict against J&J for its baby powder, scientists interviewed post-trial cast doubts on the claim made by the case, specifically because there has yet to be a definite link between modern-day talc and any cancers. The same has been echoed by the American Cancer Society.

But that won’t stop the trial lawyers who now recognize their golden goose. A record $4.7 billion verdict was delivered in Missouri in July 2018 against the pharmaceutical and consumer goods giant, and that’s proved fodder for the legal firms now lining up to cash in. And that’s because a jury has determined these products to be unsafe, rather than regulators and scientific experts. In the eyes of our legal system, juries provide more proof than actual evidence.

And considering the legal fees billed by national law firms, it’s not hard to see why these cases are so lucrative for them.

If you’ve been glued into television at all the last few years, you’ll know that between political ads, dozens of law firms around the country are aggressively soliciting plaintiffs for class-action lawsuits. “Call today, you could be compensated!” “You deserve justice now!”

Websites such as TopClassActions.com purport to “connect consumers to settlements, lawsuits, and attorneys”, and maintain an active log of thousands of open class-action lawsuits that any consumer can click and join. Their daily newsletter highlights potential awards and deadlines and gives top billing to the biggest cases with a low threshold to become a plaintiff.

While such services may be necessary for legitimate harms and victims, we must admit it’s all gotten a bit out of hand.

The tort system was devised as a way to offer justice to those who have been harmed.

Originally published here.


The Consumer Choice Center is the consumer advocacy group supporting lifestyle freedom, innovation, privacy, science, and consumer choice. The main policy areas we focus on are digital, mobility, lifestyle & consumer goods, and health & science.

The CCC represents consumers in over 100 countries across the globe. We closely monitor regulatory trends in Ottawa, Washington, Brussels, Geneva and other hotspots of regulation and inform and activate consumers to fight for #ConsumerChoice. Learn more at 
consumerchoicecenter.org

Scroll to top
en_USEN

Follow us

WASHINGTON

712 H St NE PMB 94982
Washington, DC 20002

BRUSSELS

Rond Point Schuman 6, Box 5 Brussels, 1040, Belgium

LONDON

Golden Cross House, 8 Duncannon Street
London, WC2N 4JF, UK

KUALA LUMPUR

Block D, Platinum Sentral, Jalan Stesen Sentral 2, Level 3 - 5 Kuala Lumpur, 50470, Malaysia

© COPYRIGHT 2025, CONSUMER CHOICE CENTER

Also from the Consumer Choice Center: ConsumerChamps.EU | FreeTrade4us.org